Curing HIV with Hans-Peter Kiem We have achieved major success in the HIV epidemic with antiretroviral therapy (ART). ART successfully suppresses viral replication, keeping viral levels low and in most cases undetectable, thus blocking the progression to AIDS. April 17, 2017 in VIDD News
Curing chronic viral infections with Keith Jerome It wasn’t very long ago that the idea of an HIV cure was scoffed at. The concept of a curative method for dealing with chronic viral infections, as opposed to preventative (such as vaccines) or treatment (such as antivirals), has a history of controversy among the field. Sept. 4, 2014 in VIDD News
The hunt for HIV correlates of protection with Nicole Frahm The importance of developing an effective HIV vaccine cannot be overstated. The statistics are sobering: over 35 million are infected worldwide; approximately 2 million people are infected each year; the estimated death toll from the virus thus far is 36 million; around 1.5 million died from HIV/AIDS in 2012; over 700 children become HIV infected each day. April 17, 2014 in VIDD News
Tracking down resistant strains VIDI scientists are working to develop new techniques to rapidly detect strains of novel H1N1 with resistance to oseltamivir, the common antiviral drug. Oct. 5, 2009 in VIDD News
A look at invasive fungal infections with Tobias Hohl VIDI’s newest assistant member, Dr. Tobias Hohl, is trying to track down the cells and molecules used by human immune system to battle invasive fungal infections, in an effort to improve care for immunocompromised patients who contract fungal diseases July 6, 2009 in VIDD News
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.